The estimated Net Worth of Paul Boehm is at least $5.9 Milión dollars as of 16 August 2016. Dr Boehm owns over 5,000 units of Exponent stock worth over $2,514,867 and over the last 19 years he sold EXPO stock worth over $3,389,164.
Sign up
Dr Boehm EXPO stock SEC Form 4 insiders trading
Dr has made over 14 trades of the Exponent stock since 2011, according to the Form 4 filled with the SEC. Most recently he sold 5,000 units of EXPO stock worth $260,900 on 16 August 2016.
The largest trade he's ever made was selling 10,000 units of Exponent stock on 16 May 2016 worth over $510,000. On average, Dr trades about 2,215 units every 47 days since 2006. As of 16 August 2016 he still owns at least 24,045 units of Exponent stock.
You can see the complete history of Dr Boehm stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dr. Paul D. Boehm biography
Dr. Paul D. Boehm is the Corp. VP of Environmental & Health Sciences and Principal Scientist at Exponent.
How old is Dr Boehm?
Dr Boehm is 71, he's been the Corp. VP of Environmental & Health Sciences and Principal Scientist of Exponent since . There are 2 older and 22 younger executives at Exponent. The oldest executive at Exponent Inc. is Dr. Subbaiah V. Malladi, 74, who is the CTO & Principal Engineer.
What's Dr Boehm's mailing address?
Paul's mailing address filed with the SEC is 149 COMMONWEATH DRIVE, , MENLO PARK, CA, 94025.
Insiders trading at Exponent
Over the last 21 years, insiders at Exponent have traded over $73,571,565 worth of Exponent stock and bought 2,000 units worth $170,360 . The most active insiders traders include Paul R Johnston, Richard L Jr Schlenker a John B Shoven. On average, Exponent executives and independent directors trade stock every 11 days with the average trade being worth of $675,547. The most recent stock trade was executed by Richard L Jr Schlenker on 31 July 2024, trading 40,662 units of EXPO stock currently worth $4,339,042.
What does Exponent do?
exponent is an engineering and scientific consulting firm providing solutions to complex problems. whether the firm investigates an incident that happened in the past, or assists with the development of a new product or service, exponent offers knowledge to assist its clients make informed, intelligent decisions. exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and business today. the firm's consultants analyze failures and accidents to determine their causes and provide answers to help prevent such problems. in addition, exponent evaluates human health and environmental concerns to find cost-effective solutions. exponent’s staff of approximately 900, located in 20 offices throughout the nation and 6 international offices, combines unparalleled technical expertise with the ability, when necessary, to focus this knowledge in extreme
What does Exponent's logo look like?
Complete history of Dr Boehm stock trades at Exponent
Exponent executives and stock owners
Exponent executives and other stock owners filed with the SEC include:
-
Catherine Corrigan,
President, Chief Executive Officer, Director -
Richard Schlenker,
Chief Financial Officer, Executive Vice President, Corporate Secretary -
Dr. Catherine Ford Corrigan,
Pres, CEO & Director -
Steven Murray,
Group Vice President -
Sally Shepard,
Chief Human Resource Officer -
Richard L. Schlenker Jr.,
Exec. VP, CFO & Corp. Sec. -
Harri Kytomaa,
Group Vice President -
Dr. Maureen T. F. Reitman Sc.D., F.S.P.E., P.E.,
Corp. VP - Polymers Science & Materials Chemistry, Principal Engineer and Practice Director -
Dr. Steven J. Murray,
Group VP & Principal Engineer -
Dr. Bradley A. James Ph.D., P.E., FASM,
Corp. VP, Principal Engineer & Practice Director- Materials & Corrosion Engineering -
John Shoven,
Lead Independent Director -
Debra Zumwalt,
Independent Director -
Karen Richardson,
Independent Director -
Carol Lindstrom,
Independent Director -
Paul Johnston,
Chairman of the Board -
George Brown,
Director -
Maureen Reitman,
Group Vice President -
Richard Reiss,
Group Vice President -
John Pye,
Group Vice President -
Brad James,
Group Vice President -
Robert Haddad,
Group Vice President -
Dr. Robert D. Caligiuri FASM, P.E., Ph.D.,
Corp. VP of Materials & Corrosion Engineering and Principal Engineer -
Sally B. Shepard,
Chief HR Officer -
Dr. Paul D. Boehm,
Corp. VP of Environmental & Health Sciences and Principal Scientist -
Dr. Robert D. Caligiuri,
Corp. VP of Materials & Corrosion Engineering and Principal Engineer -
Eric R. Anderson,
VP & Corp. Controller -
Dr. Subbaiah V. Malladi,
CTO & Principal Engineer -
Dr. Bernard Ross,
Co-Founder, Chairman Emeritus & Principal Engineer -
Stephen C Riggins,
Director -
John Osteraas,
Group Vice President -
Paul Boehm,
Group Vice President -
Robert D Caligiuri,
Group Vice President -
John Joseph Doyle,
Group Vice President -
Elizabeth L Anderson,
Group Vice President -
Subbaiah V Malladi,
Chief Technical Officer -
Leslie G Denend,
Director -
Robert C Lange,
Group Vice President -
John E Moalli,
Group -
Samuel H Armacost,
Director -
Jon R Katzenbach,
Director -
Mary B Cranston,
Director -
Michael R Gaulke,
President & CEO -
Barbara M Barrett,
Director -
Roger L Mccarthy,
Chairman, -
Charles A Jr Rau,
Corporate Vice President -
Larry W Anderson,
Group Vice President -
Edward J Keith,
Director -
Angela A Meyer,
Vice President Client Services -
Piotr D Moncarz,
Corporate Vice President -
Joseph Rakow,
Group Vice President -
Eric Guyer,
Group Vice Presient